Barriers to Molecular Research in Gliomas: Implications for Precision Medicine in Resource-Limited Nations - Takeaways - MDSpire

Barriers to Molecular Research in Gliomas: Implications for Precision Medicine in Resource-Limited Nations

  • By

  • Pablo S. Paolinelli

  • Tomas Saavedra Azcona

  • Florencia B. Casto

  • Ezequiel Jungberg

  • Nicolás Tilano

  • William A. Blettler

  • Joan S. Pazos

  • Silvina Dell’Era

  • Clara Lynch

  • Miguel Villaescusa

  • Pedro Plou

  • Pablo Ajler

  • April 20, 2026

  • 0 min

Share

  • 1

    CNS tumors, particularly gliomas, pose significant diagnostic challenges due to their heterogeneity and evolving classification criteria.

  • 2

    The WHO classifications of CNS tumors have progressively integrated molecular markers, enhancing diagnostic accuracy but complicating tumor characterization.

  • 3

    In resource-limited countries, limited access to molecular testing hinders the full application of WHO classification criteria for gliomas.

  • 4

    A retrospective study at a Latin American neurosurgical center revealed increased cases of incomplete tumor characterization with newer WHO classifications.

  • 5

    The reliance on external laboratories for molecular testing in developing regions delays diagnoses and negatively impacts treatment decisions.

Original Source(s)

Related Content